Authors/Disclosures
|
Deniz Erten-Lyons, MD, FÂ鶹´«Ã½Ó³»
(FDA)
|
Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |
|
Nina M. Browner, MD
(Department of Neurology, University of North Carolina)
|
The institution of Dr. Browner has received research support from Parkinson Foundation Center of Excellence Grant. The institution of Dr. Browner has received research support from Parkinson Foundation Community Outreach Grant . |
|
Shannon McWeeney
|
No disclosure on file |
|
Beth Wilmot, MS
(Oregon Health & Science University)
|
No disclosure on file |
|
Patricia L. Kramer, PhD
(Oregon Health Sciences University)
|
No disclosure on file |
|
Jeffrey A. Kaye, MD, FÂ鶹´«Ã½Ó³»
(Oregon Hlth Sci Univ.)
|
Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
|
Douglas M. Turnbull
(Univ of Newcastle Upon Tyne Dept of Neurology)
|
No disclosure on file |